Cargando…
A repository of protein abundance data of drug metabolizing enzymes and transporters for applications in physiologically based pharmacokinetic (PBPK) modelling and simulation
Population factors such as age, gender, ethnicity, genotype and disease state can cause inter-individual variability in pharmacokinetic (PK) profile of drugs. Primarily, this variability arises from differences in abundance of drug metabolizing enzymes and transporters (DMET) among individuals and/o...
Autores principales: | Ladumor, Mayur K., Thakur, Aarzoo, Sharma, Sheena, Rachapally, Aravind, Mishra, Sarang, Bobe, Priyanka, Rao, V. Kameswara, Pammi, Praneetha, Kangne, Hari, Levi, David, Balhara, Ankit, Ghandikota, Sriram, Joshi, Anupama, Nautiyal, Vivek, Prasad, Bhagwat, Singh, Saranjit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6609630/ https://www.ncbi.nlm.nih.gov/pubmed/31273226 http://dx.doi.org/10.1038/s41598-019-45778-9 |
Ejemplares similares
-
Contribution of Uptake and Efflux Transporters to
Oral Pharmacokinetics of Furosemide
por: Chapa, Revathi, et al.
Publicado: (2020) -
Applied Concepts in PBPK Modeling: How to Build a PBPK/PD Model
por: Kuepfer, L, et al.
Publicado: (2016) -
Estimation of Fetal-to-Maternal Unbound Steady-State Plasma Concentration Ratio of P-Glycoprotein and/or Breast Cancer Resistance Protein Substrate Drugs Using a Maternal-Fetal Physiologically Based Pharmacokinetic Model
por: Peng, Jinfu, et al.
Publicado: (2022) -
Application of Physiologically Based Pharmacokinetic (PBPK) Modeling to Support Dose Selection: Report of an FDA Public Workshop on PBPK
por: Wagner, C, et al.
Publicado: (2015) -
PBPK modeling and simulation in drug research and
development
por: Zhuang, Xiaomei, et al.
Publicado: (2016)